Xencor | GJELD



Debt Endring Dato
AbbVie USD 67.14B 3.94B 2024-12
Alnylam Pharmaceuticals USD 1.02B 967K 2024-12
Amgen USD 60.1B 299M 2024-12
Arrowhead Research USD 409.41M 16.23M 2024-12
AstraZeneca USD 31.65B 1.35B 2025-03
Biogen USD 6.3B 1.9M 2024-12
Bristol-Myers Squibb USD 49.71B 62M 2025-03
Cytokinetics USD 657.12M 1.1M 2024-12
GlaxoSmithKline GBP 18.43B 1.45B 2025-03
J&J USD 52.25B 15.62B 2025-03
MacroGenics USD 0 0 2024-12
Merck USD 37.11B 1.02B 2024-12
Novartis USD 31.26B 828M 2024-12
Pfizer USD 64.35B 3.35B 2024-12
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Roche Holding CHF 34.44B 5.23B 2024-06
Xencor USD 163.61M 145.69M 2024-12



Xencor GJELD - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.